medmix AG (MEDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, medmix AG (MEDX) has a cash flow conversion efficiency ratio of 0.086x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF37.40 Million ≈ $47.28 Million USD) by net assets (CHF432.80 Million ≈ $547.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See medmix AG (MEDX) defensive interval to measure how many days the company can operate on defensive assets alone.
medmix AG - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how medmix AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
medmix AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of medmix AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Archer Ltd.
LSE:0RBA
|
0.017x |
|
Cogeco Inc.
TO:CGO
|
0.047x |
|
Ningbo Joy Intelligent Logistics Technology Co.Ltd.
SHE:301198
|
0.017x |
|
Rojana Industrial Park Public Company Limited
BK:ROJNA
|
0.089x |
|
Third Point Investors Limited
LSE:TPOU
|
-0.004x |
|
Emeco Holdings Ltd
AU:EHL
|
0.189x |
|
Boston Omaha Corp
NYSE:BOC
|
0.011x |
|
Hangzhou Todaytec Digital Co Ltd Class A
SHE:300743
|
0.060x |
Annual Cash Flow Conversion Efficiency for medmix AG (2018–2025)
The table below shows the annual cash flow conversion efficiency of medmix AG from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see MEDX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF432.80 Million ≈ $547.18 Million |
CHF67.80 Million ≈ $85.72 Million |
0.157x | -19.19% |
| 2024-12-31 | CHF446.70 Million ≈ $564.75 Million |
CHF86.60 Million ≈ $109.49 Million |
0.194x | +63.94% |
| 2023-12-31 | CHF474.40 Million ≈ $599.77 Million |
CHF56.10 Million ≈ $70.93 Million |
0.118x | +25.41% |
| 2022-12-31 | CHF504.80 Million ≈ $638.20 Million |
CHF47.60 Million ≈ $60.18 Million |
0.094x | -42.33% |
| 2021-12-31 | CHF533.90 Million ≈ $674.99 Million |
CHF87.30 Million ≈ $110.37 Million |
0.164x | +7.74% |
| 2020-12-31 | CHF333.40 Million ≈ $421.51 Million |
CHF50.60 Million ≈ $63.97 Million |
0.152x | -49.73% |
| 2019-12-31 | CHF295.10 Million ≈ $373.09 Million |
CHF89.10 Million ≈ $112.65 Million |
0.302x | +8.88% |
| 2018-12-31 | CHF339.70 Million ≈ $429.47 Million |
CHF94.20 Million ≈ $119.09 Million |
0.277x | -- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more